ADVERTISEMENT
Mold-Tek Packaging Q4 Review: IDBI Capital Maintains 'Buy', Hikes Target Price Post Inline Results
Volume growth seems back on track, says IDBI Capital, maintaining 'Buy' on the stock
20 May 2025, 03:27 PM IST 
Mold-Tek Packaging's pharma- Pack division sales almost tripled to Rs 66.7 million in Q4 FY25 compared to Q3 FY25, crossed breakeven and started contributing to the bottom line. (Source: Comapny website)
The brokerage continues to like Mold-Tek Packaging given its strategy of timely capacity expansion and entry into high value products. The management’s focus on high margin Food and FMCG, foray into pharma segment and timely capacity addition for paints division would pave the way for future earnings growth.
I’m already a Subscriber
To continue reading this storySubscribe to Unlock & Enjoy your
Subscriber-Only benefits
Subscriber-Only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Lite
Experience
Subscriber-Only
Rewards
NDTV Profit
Exclusive Stories
Full Access to
NDTV Profit App
Access to
Stories20,000+
Research Reports
Ad-Lite
Experience
NDTV Profit
Exclusive Stories
Curated
Newsletters
Priority Pass
to Special Events
Subscriber-Only
Rewards
Full Access to
NDTV Profit App
Still Not convinced ? Know More
